Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Subretinal timrepigene emparvovec in adult men with choroideremia: a randomized phase 3 trial.

Journal article

MacLaren RE. et al, (2023), Nat Med, 29, 2464 - 2472

Choroideremia: The Endpoint Endgame.

Journal article

Abdalla Elsayed MEA. et al, (2023), Int J Mol Sci, 24

Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy.

Journal article

Shamsnajafabadi H. et al, (2023), Cells, 12

Choroideremia: Toward Regulatory Approval of Retinal Gene Therapy.

Journal article

Yusuf IH. and MacLaren RE., (2023), Cold Spring Harb Perspect Med

Microperimetry as an Outcome Measure in RPGR-associated Retinitis Pigmentosa Clinical Trials.

Journal article

Taylor LJ. et al, (2023), Transl Vis Sci Technol, 12

Microperimetry Reliability Assessed From Fixation Performance.

Journal article

Josan AS. et al, (2023), Transl Vis Sci Technol, 12

AAV2-Mediated Gene Therapy for Choroideremia: 5-Year Results and Alternate Anti-sense Oligonucleotide Therapy

Journal article

Zhai Y. et al, (2023), American Journal of Ophthalmology, 248, 145 - 156

Is RPGR-related retinal dystrophy associated with systemic disease? A case series.

Journal article

Han RC. et al, (2023), Ophthalmic Genet, 1 - 8

Clinical Research on the Leading Causes of Severe Sight Impairment in the UK General and Working Populations.

Journal article

Liu WJ. et al, (2023), Clin Ophthalmol, 17, 2729 - 2735

Load More